The main purpose of this study is to get the urethra and pelvic sonographic imaging by 4D ultrasound examinations, and to correlate the sonographic findings with urodynamic variables, pad weights and LUTS. Besides, the associations of the blood flow of vagina/urethra and sexual dysfunction can be explored.

Population

Women with lower urinary tract symptoms

Brief Title

Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.

Official Title

Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.

Brief Summary

The main purpose of this study is to get the urethra and pelvic sonographic imaging by 4D<br /> ultrasound examinations, and to correlate the sonographic findings with urodynamic variables,<br /> pad weights and LUTS. Besides, the associations of the blood flow of vagina/urethra and<br /> sexual dysfunction can be explored.

Detailed Description

Female lower urinary tract dysfunction includes stress urinary incontinence, overactive
bladder syndrome and voiding dysfunction. There are a lot of bladder studies, such as
researches of bladder wall thickness and bladder volume. However, there were few studies of
urethra for female patients with lower urinary tract symptoms (LUTS), especially for storage
disorder. Thus, the main purpose of this study is to get the urethra and pelvic sonographic
imaging by 4D ultrasound examinations, and to correlate the sonographic findings with
urodynamic variables, pad weights and LUTS. The investigators hope to identify important LUTS
sonographic biomarkers that can be used by primary physicians as a tool for assess female
LUTS, and thus decreasing the need of further invasive urodynamic studies.

Besides, the associations of the blood flow of vagina/urethra and sexual dysfunction
(assessed by female sexual function index) can be explored.

In addition, women who receive antimuscarinics treatment will receive follow-up 4D imaging
and request to complete questionnaire 12 weeks later.

Outcome Measures

Outcome measures are the tests that investigators perform to prove whether or not a treatment being tested in a clinical trial is having any effect.